These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34222733)

  • 1. Global Landscape of Glioblastoma Multiforme Management in the Stupp Protocol Era: Systematic Review Protocol.
    Adegboyega G; Kanmounye US; Petrinic T; Ozair A; Bandyopadhyay S; Kuri A; Zolo Y; Marks K; Ramjee S; Baticulon RE; Vaqas B;
    Int J Surg Protoc; 2021 Jun; 25(1):108-113. PubMed ID: 34222733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival times of patients with glioblastoma in low- and middle-income countries: a systematic review and meta-analysis.
    Dy LF; Ong EP; Espiritu AI; Spears J; Omar AT
    Neurosurg Rev; 2022 Oct; 45(5):3393-3403. PubMed ID: 36044130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China.
    Wang Y; Zhang J; Li W; Jiang T; Qi S; Chen Z; Kang J; Huo L; Wang Y; Zhuge Q; Gao G; Wu Y; Feng H; Zhao G; Yang X; Zhao H; Wang Y; Yang H; Kang D; Su J; Li L; Jiang C; Li G; Qiu Y; Wang W; Wang H; Xu Z; Zhang L; Wang R
    Future Oncol; 2021 Nov; 17(33):4571-4582. PubMed ID: 34519220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Survival Analysis with Identification of Prognostic Factors in a Series of 110 Patients with Newly Diagnosed Glioblastoma Before and After Introduction of the Stupp Regimen: A Single-Center Observational Study.
    Illic R; Somma T; Savic D; Frio F; Milicevic M; Solari D; Nikitovic M; Lavrnic S; Raicevic S; Milosevic S; Cavallo LM; Cappabianca P; Grujicic D
    World Neurosurg; 2017 Aug; 104():581-588. PubMed ID: 28522381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: Single-center experience.
    Lukács G; Tóth Z; Sipos D; Csima M; Hadjiev J; Bajzik G; Cselik Z; Semjén D; Repa I; Kovács Á
    Ideggyogy Sz; 2018 Mar; 71(3-04):95-103. PubMed ID: 29889468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
    Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol.
    Topkan E; Kucuk A; Ozdemir Y; Mertsoylu H; Besen AA; Sezen D; Bolukbasi Y; Pehlivan B; Selek U
    J Immunol Res; 2020; 2020():8628540. PubMed ID: 33274245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and Outcomes of Low-Grade Gliomas in Africa: A Scoping Review Protocol.
    Ooi SZY; de Koning R; Egiz A; Dalle DU; Denou M; Tsopmene MRD; Khan M; Takoukam R; Kotecha J; Sichimba D; Dokponou YCH; Kanmounye US; Bankole NDA
    Int J Surg Protoc; 2022; 26(1):1-6. PubMed ID: 35178489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit of concomitant chemoradiation in adult supratentorial primary glioblastoma. A propensity score weighted population-based analysis.
    Jusue-Torres I; Hulbert A; Barton K; Melian E; Anderson DE; Quiñones-Hinojosa A; Prabhu VC
    J Neurosurg Sci; 2022 Dec; 66(6):542-550. PubMed ID: 32972114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcomes of glioblastoma multiforme in low and middle-income countries: current state and future directions.
    Abdulbasit Opeyemi M; Aderinto N; Akinmeji A; Mustapha FB; Mubarak JM; Joshua AY; Kuol PP; Rebecca Opeyemi A; Alare K; Olatunji G; Emmanuel K
    Ann Med Surg (Lond); 2024 Sep; 86(9):5326-5333. PubMed ID: 39239018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of severe maternal morbidity on adverse perinatal outcomes in high-income countries: systematic review and meta-analysis protocol.
    Mengistu TS; Turner J; Flatley C; Fox J; Kumar S
    BMJ Open; 2019 Jun; 9(6):e027100. PubMed ID: 31213449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma management in low and middle-income countries; existing challenges and policy recommendations.
    Tebha SS; Ali Memon S; Mehmood Q; Mukherjee D; Abdi H; Negida A
    Brain Spine; 2023; 3():101775. PubMed ID: 38021027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Global Impact of COVID-19 on Childhood Cancer Outcomes and Care Delivery - A Systematic Review.
    Majeed A; Wright T; Guo B; Arora RS; Lam CG; Martiniuk AL
    Front Oncol; 2022; 12():869752. PubMed ID: 35463381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Immunohistochemical profiling of Glioblastoma multiforme on clinical outcomes: Real-world scenario in resource limited setting.
    Kumar N; Elangovan A; Madan R; Dracham C; Khosla D; Tripathi M; Gupta K; Kapoor R
    Clin Neurol Neurosurg; 2021 Aug; 207():106726. PubMed ID: 34116459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival.
    Huang B; Yu Z; Liang R
    BMC Neurol; 2021 Nov; 21(1):424. PubMed ID: 34724914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of interventions for dementia in low- and middle-income countries: protocol for a systematic review, pairwise and network meta-analysis.
    Salcher-Konrad M; Naci H; McDaid D; Alladi S; Oliveira D; Fry A; Hussein S; Knapp M; Musyimi CW; Ndetei DM; Lopez-Ortega M; Comas-Herrera A
    BMJ Open; 2019 Jun; 9(6):e027851. PubMed ID: 31221887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenges of managing glioblastoma multiforme in developing countries: a trade-off between cost and quality of care.
    Salem A; Hashem SA; Al-Rashdan A; Ezam N; Nour A; Alsharbaji A; Sughayer M; Mohamad I; Elyan M; Addas A; Al-Hussaini M; Almousa A
    Hematol Oncol Stem Cell Ther; 2011; 4(3):116-20. PubMed ID: 21982884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.